# reload+after+2024-01-22 12:47:02.809132
address1§1001 Calle Amanecer
city§San Clemente
state§CA
zip§92673
country§United States
phone§949 429 6680
website§https://www.reshapelifesciences.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
fullTimeEmployees§40
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Dan W. Gladney', 'age': 70, 'title': 'Executive Chair', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 95261, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Paul F. Hickey', 'age': 58, 'title': 'CEO, President & Director', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 158078, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Thomas  Stankovich', 'age': 62, 'title': 'Chief Financial Officer', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 555838, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mark B. Knudson Ph.D.', 'age': 74, 'title': 'Co-Founder and Special Advisor to the CEO', 'yearBorn': 1949, 'fiscalYear': 2022, 'totalPay': 33000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Katherine S. Tweden Ph.D.', 'age': 62, 'title': 'Co-Founder', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 338412, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Al  Diaz', 'title': 'Vice President of Operations and R&D', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Dov  Gal D.V.M., M.B.A.', 'title': 'VP of Regulatory Clinical Quality & Compliance Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Jody B. Dahlman', 'title': 'Director of Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Naqeeb A. Ansari', 'age': 62, 'title': 'Senior Vice President of Global Commercial Operations', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 327464, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.305
priceToSalesTrailing12Months§0.4283665
currency§USD
dateShortInterest§1702598400
forwardEps§-0.45
exchange§NCM
quoteType§EQUITY
shortName§ReShape Lifesciences, Inc.
longName§ReShape Lifesciences Inc.
firstTradeDateEpochUtc§1475760600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§cf131b5d-c254-3c24-b916-392db27496a4
gmtOffSetMilliseconds§-18000000
targetHighPrice§1.0
targetLowPrice§1.0
targetMeanPrice§1.0
targetMedianPrice§1.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§0.806
grossMargins§0.5411
ebitdaMargins§-1.76565
trailingPegRatio§None
